Institutional members access full text with Ovid®

Share this article on:

Patient Management Problem—Preferred Responses

Pierce, Aimee MD

CONTINUUM: Lifelong Learning in Neurology: April 2013 - Volume 19 - Issue 2, Dementia - p 525–537
doi: 10.1212/01.CON.0000429165.20191.49
CME

Address correspondence to Dr Aimee Pierce, University of California, Irvine, Neurology, 1100 Gottschalk Medical Plaza, Irvine, CA 92697, piercea@uci.edu.

Relationship Disclosure: Dr Pierce has received personal compensation for survey participation from LeadPhysician.

Unlabeled Use of Products/Investigational Use Disclosure: Dr Pierce discusses the unlabeled use of donepezil, galantamine, and rivastigmine for the treatment of mild cognitive impairment, and the unlabeled use of quetiapine for the treatment of dementia-related psychosis.

© 2013 American Academy of Neurology
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website